| Trial ID: | L0046 |
| Source ID: | NCT04640324
|
| Associated Drug: |
PNPLA3
|
| Title: |
Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease|Insulin Resistance
|
| Interventions: |
Drug: Nutraceutical therapy
|
| Outcome Measures: |
Number of participants in each study group which shown an improvement from baseline of insulin resistance assed by HOMA-IR|Mean change in ALT levels from baseline|Mean change in insulin levels from baseline|Mean change in CRP levels from baseline|Mean change in TBARS levels from baseline
|
| Sponsor/Collaborators: |
University of Campania "Luigi Vanvitelli"|Federico II University|University of Salerno
|
| Gender: |
All
|
| Age: |
18 Years to 80 Years ?? (Adult, Older Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
92
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
January 16, 2017
|
| Completion Date: |
April 17, 2018
|
| Results First Posted: |
--
|
| Last Update Posted: |
November 24, 2020
|
| Locations: |
University of Salerno, Fisciano, Salerno, Italy|University of Campania "Luigi Vanvitelli", Naples, Italy|University of Naples "Federico II), Naples, Italy
|
| URL: |
https://ClinicalTrials.gov/show/NCT04640324
|
